Cytek Biosciences, Inc. provided revenue guidance for the fiscal year 2022. Cytek Biosciences expects full year 2022 revenue to be in the range of $160 million to $168 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.96 USD | +0.68% | -2.30% | -34.65% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.65% | 782M | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.05% | 65.01B | |
+15.38% | 53.02B | |
+3.96% | 50.45B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |
- Stock Market
- Equities
- CTKB Stock
- News Cytek Biosciences, Inc.
- Cytek Biosciences, Inc. Provides Revenue Guidance for the Fiscal Year 2022